Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-01 · accession 0001454983-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2026-02-01 | KNSA | Levy Richard S | Dir | M - OptEx | — | +683 | 19.2K | +4% | — |
| D | 2026-02-04 | 2026-02-01 | KNSA | Levy Richard S | Dir | M - OptEx | $0.00 | -683 | 0 | -100% | $0 |
| D | 2026-02-04 | 2026-02-01 | KNSA | Levy Richard S | Dir | A - Grant | $0.00 | +683 | 683 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-02-01 | M | A | 683 | — | 19,157 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Derivative | Restricted Share Units | 2026-02-01 | M | D | 683 | $0.00 | 0 | D | — · — to — | 683 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs. |
| 3 | Derivative | Restricted Share Units | 2026-02-01 | A | A | 683 | $0.00 | 683 | D | — · — to — | 683 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs. |